Top Markets
#1 Cortex Cortex +32.42%
#2 龙虾 (Lobster) 龙虾 (Lobster) +30.38%
#3 Akedo Akedo +25.48%
#4 DexNet DexNet +23.19%
#5 Pons Pons +21.68%
#6 wojak wojak +16.75%
#7 APEX APEX +13.93%
#8 OpenEden OpenEden +13.55%
#9 Official Trump Official Trump +11.37%
#10 EXOD EXOD +9.04%
Coin of the day
Cortex Cortex
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
HBM Holdings Limited HBM Holdings Limited

HBM Holdings Limited

2142
Rang in Aktien #7239
HBM Holdings Limited is a clinical-stage biopharmaceutical enterprise focused... HBM Holdings Limited is a clinical-stage biopharmaceutical enterprise focused on identifying and developing unique antibody-based treatments for a variety of immunological conditions and cancers. The company's pipeline includes several promising assets. In immunology, Batoclimab (HBM9161) is a human monoclonal antibody specifically designed to bind and inhibit the neonatal fragment crystallizable receptor, while Tanfanercept (HBM9036) is under development to address moderate to severe dry eye disease. For oncology, HBM Holdings is advancing various therapies, such as HBM7008, a bispecific antibody targeting tumor-associated antigens, and HBM4003, a human anti-CTLA-4 antibody. Additional cancer candidates in their portfolio include HBM9302 for breast and gastric cancers, HBM7020 for multiple myeloma, and a suite of treatments—HBM1007, HBM1029, HBM7015, HBM7008, and HBM1022—geared towards solid tumors. Furthermore, HBM9022 is being developed to treat SARS-COV-2. Operating globally, HBM Holdings has a presence in Mainland China, the United States, Europe, and other international markets. The company also fosters strategic partnerships for antibody-drug conjugate (ADC) projects with LegoChem Biosciences Inc. and Duality Biotherapeutics, Inc. HBM Holdings Limited was founded in 2016 and is based in Shanghai, People's Republic of China.
Aktienkurs
$1.99
Marktkapitalisierung
$1.67B
Veränderung (1 Tag)
-4.66%
Veränderung (1 Jahr)
22.01%
Land
CN
Handel HBM Holdings Limited (2142)

Kategorie

Healthcare
Dividendenhistorie für HBM Holdings Limited (2142)
HBM Holdings Limited (Aktienkürzel: 2142) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für HBM Holdings Limited (2142) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Dividendenzahlungen Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH